Literature DB >> 18474824

Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection.

Robert A Kloner1, Richard W Nesto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18474824     DOI： 10.1161/CIRCULATIONAHA.107.697979

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  14 in total

Review 1.  Critical illness hyperglycemia in pediatric cardiac surgery.

Authors:  Kalia P Ulate; Shekhar Raj; Alexandre T Rotta
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

2.  Usefulness of serum unbound free fatty acid levels to predict death early in patients with ST-segment elevation myocardial infarction (from the Thrombolysis In Myocardial Infarction [TIMI] II trial).

Authors:  Andrew H Huber; J Patrick Kampf; Thomas Kwan; Baolong Zhu; Jesse Adams; Alan M Kleinfeld
Journal:  Am J Cardiol       Date:  2013-10-05       Impact factor: 2.778

Review 3.  Myocardial ischemia reperfusion injury: from basic science to clinical bedside.

Authors:  Anja Frank; Megan Bonney; Stephanie Bonney; Lindsay Weitzel; Michael Koeppen; Tobias Eckle
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2012-02-23

Review 4.  Myocardial remote ischemic preconditioning: from cell biology to clinical application.

Authors:  Martín Donato; Ricardo J Gelpi; Eliana P Bin; Verónica D Annunzio
Journal:  Mol Cell Biochem       Date:  2021-06-14       Impact factor: 3.396

5.  Cardiomyocyte aldose reductase causes heart failure and impairs recovery from ischemia.

Authors:  Ni-Huiping Son; Radha Ananthakrishnan; Shuiqing Yu; Raffay S Khan; Hongfeng Jiang; Ruiping Ji; Hirokazu Akashi; Qing Li; Karen O'Shea; Shunichi Homma; Ira J Goldberg; Ravichandran Ramasamy
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

Review 6.  Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1.

Authors:  Sophie J Clarke; Liam M McCormick; David P Dutka
Journal:  Cardiovasc Diabetol       Date:  2014-01-11       Impact factor: 9.951

7.  Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis.

Authors:  Satoshi Ito; Tomohisa Nagoshi; Kosuke Minai; Yusuke Kashiwagi; Hiroshi Sekiyama; Akira Yoshii; Haruka Kimura; Yasunori Inoue; Kazuo Ogawa; Toshikazu D Tanaka; Takayuki Ogawa; Makoto Kawai; Michihiro Yoshimura
Journal:  PLoS One       Date:  2017-04-21       Impact factor: 3.240

8.  Transient decrease in serum potassium level during ischemic attack of acute coronary syndrome: paradoxical contribution of plasma glucose level and glycohemoglobin.

Authors:  Hiroshi Sekiyama; Tomohisa Nagoshi; Kimiaki Komukai; Masato Matsushima; Daisuke Katoh; Kazuo Ogawa; Kosuke Minai; Takayuki Ogawa; Michihiro Yoshimura
Journal:  Cardiovasc Diabetol       Date:  2013-01-04       Impact factor: 9.951

9.  Uncoupling protein 3 deficiency impairs myocardial fatty acid oxidation and contractile recovery following ischemia/reperfusion.

Authors:  Kristin S Edwards; Sadia Ashraf; Tyler M Lomax; Jessica M Wiseman; Michael E Hall; Fabio N Gava; John E Hall; Jonathan P Hosler; Romain Harmancey
Journal:  Basic Res Cardiol       Date:  2018-10-29       Impact factor: 17.165

Review 10.  Glucagon-Like Peptide-1: A Promising Agent for Cardioprotection During Myocardial Ischemia.

Authors:  Joel P Giblett; Sophie J Clarke; David P Dutka; Stephen P Hoole
Journal:  JACC Basic Transl Sci       Date:  2016-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.